Revitaderm Psoriasis Ointment
Product Images NDC 63347-112

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revitaderm Psoriasis (NDC 63347-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blaine Labs Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blaine_revitaderm_psoriasis1 (Blaine Revitaderm Psoriasis1)

RevitaDERM is a proven formula for treating psoriasis. It recommends applying the formula up to four times a day to affected areas. The formula includes Colloidal silver to help prevent infection.*

FDA Label Image

Blaine_revitaderm_psoriasis2 (Blaine Revitaderm Psoriasis2)

RevitaDERM® PSORIASIS OINTMENT is a specially formulated product with selected ingredients to alleviate the symptoms of psoriasis, eczema, and sebhorreic dermatitis. Its formula contains Colloidal Silver, which has antimicrobial properties. The ointment is guaranteed to reduce itching, flaking, redness, scaling, and prevent infection. It acts faster with a reduced odor. Additionally, it also helps relieve itching and other symptoms associated with eczema and sebhorreic dermatitis. NDC #63347-112-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.